Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126582) titled 'Efficacy of Alpha-Lipoic Acid Capsules in Diabetic Optic Neuropathy: A Randomized Controlled Trial' on June 11.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chinese People's Liberation Army General Hospital
Condition:
Diabetic optic neuropathy
Intervention:
Intervention :oral alpha-lipoic acid (ALA) capsules
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2023-02-09
Target Sample Size: Intervention :53;Control:53;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=323499
Disclaimer: Curated by HT Syndica...